Product · Healthcare & Life Sciences

iCare — intelligent rare disease management

A platform for government healthcare establishments managing lifelong rare disease care — one place for patients, treatment, stock and reporting.

The problem it solves

Rare disease care is lifelong and data-heavy. Patients with conditions such as Hemophilia, Thalassemia and Sickle Cell Disease need structured treatment, regular factor or blood support, and consistent follow-up over decades. In public healthcare settings that work is often spread across paper registers, spreadsheets and separate stock systems. Clinicians end up without a single view of a patient's journey, administrators can't see stock levels across sites, and reporting becomes a manual exercise that is slow and easy to get wrong.

Who it's for

iCare is built for government healthcare establishments and programme teams responsible for rare disease care — clinicians who record and follow treatment, pharmacists and stores staff who manage factor and blood products, and state-level administrators who need transparent, auditable reporting across many sites and thousands of patients.

What it does

Patient registry and longitudinal records — one record per patient that follows them across visits, sites and years of care.

Treatment and infusion tracking — what was given, when, by whom, and what happened next.

Blood and factor inventory management — stock levels, consumption and replenishment visibility so treatment isn't delayed by avoidable stock-outs.

Role-based dashboards — clinicians and administrators each see the view they need, and only that.

Healthcare workflows — structured care pathways that keep steps consistent between sites and shifts.

Reporting — programme and compliance reporting generated from the same data clinicians already enter, rather than assembled by hand.

Interoperability roadmap — integration with external health systems is scoped as a roadmap item against what each deployment can actually support.

How it's built

iCare is a web platform designed for the realities of public health: role-based access control, an audit trail behind clinical actions, and an architecture that scales across many institutions without every site running its own copy of the truth. Data entered once is reused for care, stock management and reporting — which is what makes the reporting trustworthy in the first place.

Recognition and status

iCare is in use with government healthcare institutions and has been recognised by the World Federation of Hemophilia (WFH) for its contribution to strengthening hemophilia management systems. The platform continues to evolve, with predictive analytics and critical-care enhancements on the roadmap.

We do not publish compliance certifications or clinical outcome metrics here unless they have been formally verified for a specific deployment. If you need details for a procurement or audit process, ask us and we will tell you exactly what is implemented, what is in progress and what is not applicable.

What we'd build next for you

If your organisation needs a patient registry, treatment tracking or a clinical workflow platform, the same engineering team that built iCare can scope it. We start with the care pathway and the reporting obligation, then design the system around them — and we'll tell you honestly if a smaller first slice would prove the value faster.